Method of predicting the responsiveness oa a tumor to erbB receptor drugs

Details for Australian Patent Application No. 2005263972 (hide)

Owner AstraZeneca AB

Inventors Marshall, Gayle; South, Marie Caroline; Sam, Mehran; Hudson, Kevin

Agent Davies Collison Cave

Pub. Number AU-A-2005263972

PCT Pub. Number WO2006/008526

Priority 60/590,357 23.07.04 US; 60/619,027 18.10.04 US

Filing date 20 July 2005

Wipo publication date 26 January 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/008526 Priority application(s): WO2006/008526

19 April 2007 Amendment Made

  The nature of the amendment is: Amend the invention title to read Method of predicting the responsiveness of a tumor to erbB receptor drugs

21 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263977-Interrogation of a sensor

2005263971-Treatment of burns